Chronic intestinal pseudo-obstruction: associations with gut microbiota and genes expression of intestinal serotonergic pathway

Giulia Radocchia,Massimiliano Marazzato,Karim Ben Harbi,Elena Capuzzo,Fabrizio Pantanella,Roberto De Giorgio,Matteo Guarino,Anna Costanzini,Letizia Zenzeri,Pasquale Parisi,Alessandro Ferretti,Enrico Felici,Anna Teresa Palamara,Giovanni Di Nardo,Serena Schippa
DOI: https://doi.org/10.1186/s12866-024-03200-z
IF: 4.465
2024-02-04
BMC Microbiology
Abstract:Pediatric chronic intestinal pseudo-obstruction (PIPO) is a rare disease characterized by symptoms and radiological signs suggestive of intestinal obstruction, in the absence of lumen-occluding lesions. It results from an extremely severe impairment of propulsive motility. The intestinal endocrine system (IES) jointly with the enteric nervous system (ENS) regulates secreto-motor functions via different hormones and bioactive messengers/neurotransmitters. The neurotransmitter 5-hydroxytryptamine (5-HT) (or serotonin) is linked to intestinal peristalsis and secretory reflexes. Gut microbiota and its interplay with ENS affect 5-HT synthesis, release, and the subsequent serotonin receptor activation. To date, the interplay between 5-HT and gut microbiota in PIPO remains largely unclear. This study aimed to assess correlations between mucosa associated microbiota (MAM), intestinal serotonin-related genes expression in PIPO. To this purpose, biopsies of the colon, ileum and duodenum have been collected from 7 PIPO patients, and 7 age-/sex-matched healthy controls. After DNA extraction, the MAM was assessed by next generation sequencing (NGS) of the V3-V4 region of the bacterial RNA 16 S, on an Illumina Miseq platform. The expression of genes implicated in serotoninergic pathway ( TPH1, SLC6A4, 5-HTR3 and 5-HTR4 ) was established by qPCR, and correlations with MAM and clinical parameters of PIPO have been evaluated.
microbiology
What problem does this paper attempt to address?